Moody’s also revised the outlook for NCH Healthcare System from negative to stable due to the materially improved operating performance that NCH displayed last fiscal year, according to Moody’s.
The “A2” rating, according to Moody’s, “reflects NCH’s leading and growing market position as a full service tertiary provider in a demographically favorable primary service area…and a long standing history of successful fundraising.”
Among other things, NCH has “distinctly leading and growing market share” (77 percent in FY 2014 from 74 percent in FY 2012) within its primary service area, a large open heart program, a hip and knee replacement program that is recognized on a national level, an operating cash flow margin of 13.8 percent in FY 2014, and a strong unrestricted liquidity position, according to Moody’s.
More articles on ratings:
Fitch downgrades All Children’s Hospital bonds to ‘AA-‘ rating
Fitch affirms ‘AA’ rating on Duke University Health System’s bonds
Moody’s affirms Presbyterian Healthcare Services’ ‘A3’ bond rating
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
